首页> 外文期刊>Pharmacology: International Journal of Experimental and Clinical Pharmacology >Vanidilol: a vanilloid-type vasorelaxant and ocular hypotensive beta-adrenoceptor blocker with partial beta-2-agonist activity.
【24h】

Vanidilol: a vanilloid-type vasorelaxant and ocular hypotensive beta-adrenoceptor blocker with partial beta-2-agonist activity.

机译:凡尼地洛:一种香草醛型血管松弛药和眼部降压性β-肾上腺素受体阻滞剂,具有部分β-2-激动剂活性。

获取原文
获取原文并翻译 | 示例
           

摘要

Vanidilol, [4'-(2-hydroxy-3-(tert-butylamino)propoxy)-3'-methoxyphenyl] -benzaldehyde, newly synthesized from vanillin, is a vanilloid-type beta-adrenoceptor blocker. The beta-adrenoceptor-blocking properties of vanidilol were studied both in vivo and in vitro. Intravenous injection of vanidilol (1.0, 3.0, 5.0 mg/kg) in anesthetized Wistar rats produced a decrease in blood pressure and a dose-dependent bradycardia response. Vanidilol inhibited the tachycardia effects induced by (-)isoproterenol, but had no blocking effect on the arterial pressor responses induced by phenylephrine. In isolated guinea-pig tissues, vanidilol attenuated the (-)isoproterenol-induced positive chronotropic and inotropic effects of the atria and trachea relaxation responses in a concentration-dependent manner. The parallel shift to the right of the concentration-response curve of (-)isoproterenol suggested that the agent was a beta-adrenoceptor competitive antagonist. The apparent pA2 values for vanidilol on the right atria, left atria and trachea were 7.67 +/- 0.03, 7.89 +/- 1.02 and 7.66 +/- 0.15, respectively, denoting that vanidilol was a nonselective beta-blocker. The intrinsic sympathomimetic activity of vanidilol and propranolol was determined on isolated atria and trachea from reserpinized guinea pigs. Propranolol caused significantly negative inotropic and chronotropic effects at 10(-6) mol/l or above, whereas vanidilol possessed less cardiodepressant activities than propranolol. In reserpinized tracheal strips, vanidilol produced dose-dependent relaxant responses, but propranolol was ineffective. Preincubating the preparations with ICI 118,551 (0.1-10 nmol/l), a beta 2-adrenoceptor antagonist, significantly shifted the concentration-relaxation curves of vanidilol to a region of higher concentrations. In isolated guinea-pig thoracic aorta, vanidilol (0.1-10 mumol/l) inhibited the phenylephrine (10(-5) mol/l)-induced tonic contraction in vascular smooth muscle which was related to the block of calcium influx. In 20% saline-perfused rabbits, vanidilol showed a marked delay in intraocular pressure recovery, demonstrating an ocular hypotensive action. Binding characteristics of vanidilol and propranolol were evaluated in [3H]dihydroalprenolol binding to porcine ventricular membranes. Vanidilol was less potent than propranolol in competing for the beta-adrenoceptor-binding sites. On the other hand, vanidilol had a high hydrophilicity in comparison with propranolol. In conclusion, vanidilol exhibited nonselective beta-adrenoceptor blocking, vasorelaxant and ocular hypotensive activities, but was devoid of alpha-adrenoceptor blocking and beta 1-agonist activity. Partial beta 2-adrenoceptor agonist activity and inhibitory activity on calcium influx may share in the vasorelaxant activity.
机译:香草醛,由香草醛新合成的[4'-(2-羟基-3-(叔丁基氨基)丙氧基)-3'-甲氧基苯基]-苯甲醛是香草醛型β-肾上腺素受体阻滞剂。在体内和体外研究了瓦尼地洛的β-肾上腺素受体阻断特性。在麻醉的Wistar大鼠中静脉注射Vanidilol(1.0、3.0、5.0 mg / kg)会导致血压降低和剂量依赖性心动过缓反应。瓦尼地洛抑制(-)异丙肾上腺素诱导的心动过速作用,但对去氧肾上腺素诱导的动脉升压反应没有阻断作用。在分离的豚鼠组织中,凡尼地洛以浓度依赖的方式减弱(-)异丙肾上腺素引起的心房和气管舒张反应的正变时性和变力作用。 (-)异丙肾上腺素浓度-反应曲线右侧的平行移动表明该药物是β-肾上腺素受体竞争性拮抗剂。右心房,左心房和气管上的凡尼地洛的表观pA2值分别为7.67 +/- 0.03、7.89 +/- 1.02和7.66 +/- 0.15,表明凡尼地洛是一种非选择性β受体阻滞剂。确定了凡尼地洛和普萘洛尔的内在拟交感活性在再固定的豚鼠的心房和气管上测定。普萘洛尔在10(-6)mol / l或更高的浓度下会引起明显的负性变力和变时作用,而凡尼地洛的心律镇静活性低于普萘洛尔。在重新固定的气管带中,凡尼地洛产生剂量依赖性的松弛反应,但普萘洛尔无效。用ICI 118,551(0.1-10 nmol / l)(β2肾上腺素能受体拮抗剂)对制剂进行预温育,可将Vanidilol的浓度松弛曲线明显移至较高浓度区域。在孤立的豚鼠胸主动脉中,凡尼地洛(0.1-10μmol/ l)抑制了苯肾上腺素(10(-5)mol / l)引起的血管平滑肌的强直性收缩,这与钙流入的阻滞有关。在20%盐水灌注的兔子中,凡尼地洛在眼内压恢复中显示出明显的延迟,表明了眼压的降低。在[3H]二氢普萘洛尔与猪心室膜的结合中评估了香兰地尔和普萘洛尔的结合特性。凡尼地洛在竞争β-肾上腺素受体结合位点方面不如普萘洛尔。另一方面,凡尼地洛与普萘洛尔相比具有较高的亲水性。总之,凡尼地洛表现出非选择性的β-肾上腺素受体阻断,血管舒张和眼部降压活性,但缺乏α-肾上腺素受体阻断和β1-激动剂活性。 β2肾上腺素受体激动剂的部分活性和对钙流入的抑制活性可能与血管舒张活性有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号